The Patent Finder

Roberts Laboratories Inc.

Also on record
Records under this name other than patents Roberts Laboratories Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Roberts Laboratories Inc.

PatentTitleStatus Expires Confidence
US 6,194,4202-amino-5,6-dichloro-3,4-dihydroquinazoline, its method of making and using and pharmaceutical compositions thereof
Formerly held
Term ended
Term ended Nov 30, 2019 · From the USPTO record
Term endedTerm ended Nov 30, 2019From the USPTO record
US 6,479,529Antioxidant stabilizer system for pharmaceutical formulations
Formerly held
Lapsed on the fee record
Ended Nov 12, 2010 · From the USPTO record
Lapsed on the fee recordEnded Nov 12, 2010From the USPTO record
US 4,285,932Enzyme derivatives for use in the treatment of venous thrombosis
Term ended
Term ended no later than Aug 25, 2001 · Low confidence
Term endedTerm ended no later than Aug 25, 2001Low confidence
US 4,337,244Enzyme derivatives for use in the treatment of venous thrombosis
Term ended
Term ended no later than Jun 29, 2002 · Low confidence
Term endedTerm ended no later than Jun 29, 2002Low confidence
US 4,357,330Pharmaceutical compositions
Term ended
Term ended no later than Nov 2, 2002 · Low confidence
Term endedTerm ended no later than Nov 2, 2002Low confidence
US 4,808,405P-anisoyl streptokinase/plasminogen complex
Term ended
Term ended no later than Feb 28, 2009 · Low confidence
Term endedTerm ended no later than Feb 28, 2009Low confidence
US 5,202,435Process for the preparation of moricizine hydrochloride
Term ended
Term ended no later than Apr 13, 2013 · Low confidence
Term endedTerm ended no later than Apr 13, 2013Low confidence
US 5,334,384Process for purification of streptakinase using a reducing agent
Term ended
Term ended no later than Aug 2, 2014 · Low confidence
Term endedTerm ended no later than Aug 2, 2014Low confidence
US 5,801,245Process for the preparation of ethyl-N-(2,3 dichloro-6-nitrobenzyl) glycine
Formerly held
Term ended
Term ended no later than Sep 1, 2018 · Low confidence
Term endedTerm ended no later than Sep 1, 2018Low confidence
US 5,962,488Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives
Formerly held
Term ended
Term ended no later than Oct 5, 2019 · Low confidence
Term endedTerm ended no later than Oct 5, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited